• |
Secured a design win with a leading tier-1 automotive supplier to implement InnovizOne LiDAR in autonomous shuttles for use in European airports, campuses, local public transportation and more. The Company expects the contract to
generate hundreds of millions in revenue by 2030.
|
• |
Partnered with a leading South Korean perception software and AV technology provider, Vueron, to build an autonomous driving platform. As part of the partnership, Vueron executed a 414-kilometer, fully automated drive from Seoul to
Busan using InnovizOne LiDAR.
|
• |
Announced a partnership with Macnica, Japan’s largest distribution company, to sell InnovizOne in Japan. There has been considerable interest from customers in a number of key verticals, including automotive manufacturers as well as
leading companies in fields from construction to space travel.
|
• |
Increased manufacturing of InnovizOne at a new high-volume automotive-certified production line in Michigan. The custom designed automated manufacturing equipment successfully passed the Site Acceptance Tests (SAT).
|
• |
Released specifications for the next-generation InnovizTwo LiDAR sensor, which is expected to achieve a 30x performance improvement over InnovizOne at an approximate 70% bill of material cost reduction, with the aim of
promoting ubiquitous adoption amongst automakers.
|
• |
Launched its automotive perception platform, InnovizAPP, to key automotive customers for evaluation. The program, which is based on Innoviz’s advanced perception software, leverages sensor data and proprietary AI algorithms to
detect and classify objects in the point cloud.
|
• |
Achieved a 90% yield at Jabil’s InnovizOne production line in Jena, Germany, increasing total production capacity and providing additional prospects with samples for evaluation. The Company is working to upgrade equipment at other
production lines with the hopes of replicating the increased yield throughout its entire supply chain.
|
• |
Expanded Board of Directors with global technology and automotive industry veterans in connection with the closing of the business combination. The new appointees bring decades of experience leading publicly traded companies and
will play a key role in Innoviz’s production ramp up and global deployment.
|
• |
Closed the business combination with Collective Growth Corporation in April 2021, providing Innoviz with approximately $371 million in gross proceeds, positioning Innoviz well for its production ramp up and resulting in Innoviz’s
ordinary shares and warrants being listed on the Nasdaq Capital Market.
|
• |
Innoviz is increasing its forward-looking order book guidance by 20% to $2.4 billion, up from $2.0 billion projected earlier this year.
|
• |
Innoviz currently has 32 prospective customers in the late stages of technical evaluation, RFIs and RFQs. Of these, six are in the final commercial negotiations, or RFQ stage. These 6 prospects represent more than $3.0 billion in future
potential order book. Innoviz expects some of these projects to materialize into contractual relationships by the middle of 2022.
|
Three Months Ended March 31,
|
||||||||
2020
|
2021
|
|||||||
(Unaudited)
|
||||||||
Revenues
|
$
|
838
|
$
|
728
|
||||
Cost of revenues
|
(2,102
|
)
|
(1,459
|
)
|
||||
Gross loss
|
(1,264
|
)
|
(731
|
)
|
||||
Operating expenses:
|
||||||||
Research and development
|
$
|
15,738
|
$
|
16,733
|
||||
Selling and marketing
|
1,499
|
1,552
|
||||||
General and administrative
|
828
|
1,421
|
||||||
Total operating expenses
|
18,065
|
19,706
|
||||||
Operating loss
|
(19,329
|
)
|
(20,437
|
)
|
||||
Financial expenses, net
|
(370
|
)
|
(199
|
)
|
||||
Loss before taxes on income
|
(19,699
|
)
|
(20,636
|
)
|
||||
Taxes on income
|
(70
|
)
|
(40
|
)
|
||||
Net loss
|
$
|
(19,769
|
)
|
$
|
(20,676
|
)
|
||
Basic and diluted net loss per ordinary share
|
$
|
(1.47
|
)
|
$
|
(1.50
|
)
|
||
Weighted average number of ordinary shares used in computing basic and diluted net loss per ordinary share
|
16,269,490
|
16,966,265
|
|
December 31,
|
March 31,
|
||||||
2020
|
2021
|
|||||||
(Unaudited)
|
||||||||
ASSETS
|
||||||||
CURRENT ASSETS:
|
||||||||
Cash and cash equivalents
|
$
|
49,950
|
$
|
199,092
|
||||
Restricted deposits
|
8
|
8
|
||||||
Trade receivables
|
2,506
|
2,812
|
||||||
Inventories
|
2,164
|
3,112
|
||||||
Prepaid expenses and other current assets
|
3,287
|
4,126
|
||||||
Total current assets
|
57,915
|
209,150
|
||||||
LONG-TERM ASSETS:
|
||||||||
Restricted deposits
|
864
|
833
|
||||||
Other long-term assets
|
537
|
26,369
|
||||||
Property and equipment, net
|
13,245
|
13,309
|
||||||
Total long-term assets
|
14,646
|
40,511
|
||||||
Total assets
|
$
|
72,561
|
$
|
249,661
|
||||
LIABILITIES, CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS' DEFICIT
|
||||||||
CURRENT LIABILITIES:
|
||||||||
Trade payables
|
$
|
7,751
|
$
|
4,518
|
||||
Advances from customers and deferred revenues
|
1,661
|
3,012
|
||||||
Employees and payroll accruals
|
5,528
|
6,260
|
||||||
Accrued expenses and other current liabilities
|
2,854
|
29,632
|
||||||
Receipts on Ordinary Shares account
|
-
|
170,500
|
||||||
Total current liabilities
|
17,794
|
213,922
|
||||||
LONG-TERM LIABILITIES:
|
||||||||
Loan, net of current maturities
|
2,224
|
2,077
|
||||||
Long-term advances from customers and deferred revenues
|
3,473
|
3,473
|
||||||
Total long-term liabilities
|
5,697
|
5,550
|
||||||
Convertible preferred shares
|
272,815
|
272,815
|
||||||
SHAREHOLDERS' DEFICIT:
|
||||||||
Ordinary Shares of no-par value
|
*-
|
*-
|
||||||
Additional paid-in capital
|
7,658
|
9,453
|
||||||
Accumulated deficit
|
(231,403
|
)
|
(252,079
|
)
|
||||
Total shareholders' deficit
|
(223,745
|
)
|
(242,626
|
)
|
||||
Total liabilities, convertible preferred shares and shareholders' deficit
|
$
|
72,561
|
$
|
249,661
|
Three Months Ended March 31,
|
||||||||
2020
|
2021
|
|||||||
(Unaudited)
|
||||||||
Cash flows from operating activities:
|
||||||||
Net loss
|
$
|
(19,769
|
)
|
$
|
(20,676
|
)
|
||
Adjustments required to reconcile net loss to net cash used in operating activities:
|
||||||||
Depreciation and amortization
|
512
|
652
|
||||||
Share-based compensation
|
935
|
1,775
|
||||||
Capital gain
|
(6
|
)
|
-
|
|||||
Foreign exchange loss
|
444
|
188
|
||||||
Decrease (increase) in prepaid expenses and other assets
|
771
|
(465
|
)
|
|||||
Decrease (increase) in trade receivable
|
424
|
(306
|
)
|
|||||
Decrease (increase) in inventories
|
816
|
(948
|
)
|
|||||
Decrease in trade payables
|
(1,395
|
)
|
(3,233
|
)
|
||||
Increase in accrued expenses and other liabilities
|
872
|
572
|
||||||
Increase in employees and payroll accruals
|
539
|
732
|
||||||
Increase in advances from customers and deferred revenues
|
57
|
1,351
|
||||||
Net cash used in operating activities
|
(15,800
|
)
|
(20,358
|
)
|
||||
Cash flows from investing activities:
|
||||||||
Purchase of property and equipment
|
(1,578
|
)
|
(716
|
)
|
||||
Investment in bank deposits, net
|
(281
|
)
|
-
|
|||||
Decrease in restricted deposits
|
-
|
2
|
||||||
Net cash used in investing activities
|
(1,859
|
)
|
(714
|
)
|
||||
Cash flows from financing activities:
|
||||||||
Receipts on Ordinary shares account
|
-
|
170,500
|
||||||
Proceeds from exercise of options
|
62
|
20
|
||||||
Repayment of loan
|
(40
|
)
|
(58
|
)
|
||||
Net cash provided by financing activities
|
22
|
170,462
|
||||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash
|
(434
|
)
|
(277
|
)
|
||||
Increase (decrease) in cash, cash equivalents and restricted cash
|
(18,071
|
)
|
149,113
|
|||||
Cash, cash equivalents and restricted cash at beginning of the period
|
73,427
|
50,766
|
||||||
Cash, cash equivalents and restricted cash at end of the period
|
$
|
55,356
|
$
|
199,879
|
Three Months Ended March 31,
|
||||||||
2020
|
2021
|
|||||||
(Unaudited)
|
||||||||
Supplementary disclosure of cash flows activities:
|
||||||||
(1) Cash received during the period for:
|
||||||||
Interest
|
$
|
78
|
$
|
-
|
||||
(2) Cash paid during the period for:
|
||||||||
Interest
|
$
|
23
|
$
|
22
|
||||
Income taxes
|
$
|
70
|
$
|
37
|
||||
(3) Non-cash transactions:
|
||||||||
Non-marketable securities in consideration for property and equipment
|
$
|
21
|
$
|
69
|
||||
Deferred issuance costs
|
$
|
-
|
$
|
26,206
|
||||
(4) Cash, cash equivalents and restricted cash at end of the period
|
||||||||
Cash and cash equivalents
|
$
|
54,623
|
$
|
199,092
|
||||
Short-term restricted deposits
|
8
|
8
|
||||||
Restricted deposits
|
725
|
779
|
||||||
Cash, cash equivalents and restricted cash at end of the period
|
$
|
55,356
|
$
|
199,879
|